Published in J Virol on October 01, 1996
Complete sequence and genomic analysis of murine gammaherpesvirus 68. J Virol (1997) 7.71
Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells. J Virol (1999) 4.12
Lung epithelial cells are a major site of murine gammaherpesvirus persistence. J Exp Med (1998) 3.45
B cells regulate murine gammaherpesvirus 68 latency. J Virol (1999) 2.79
Three distinct regions of the murine gammaherpesvirus 68 genome are transcriptionally active in latently infected mice. J Virol (1999) 2.56
Disruption of the murine gammaherpesvirus 68 M1 open reading frame leads to enhanced reactivation from latency. J Virol (2000) 2.33
Maternal retinoids control type 3 innate lymphoid cells and set the offspring immunity. Nature (2014) 2.26
Gamma-herpesvirus latency is preferentially maintained in splenic germinal center and memory B cells. J Exp Med (2002) 2.20
Murine gammaherpesvirus M2 gene is latency-associated and its protein a target for CD8(+) T lymphocytes. Proc Natl Acad Sci U S A (1999) 2.19
CD4(+) T cell-mediated control of a gamma-herpesvirus in B cell-deficient mice is mediated by IFN-gamma. Proc Natl Acad Sci U S A (1999) 2.14
Helminth infection reactivates latent γ-herpesvirus via cytokine competition at a viral promoter. Science (2014) 2.04
The murine gammaherpesvirus 68 v-cyclin is a critical regulator of reactivation from latency. J Virol (2000) 2.01
Long-term latent murine Gammaherpesvirus 68 infection is preferentially found within the surface immunoglobulin D-negative subset of splenic B cells in vivo. J Virol (2003) 2.01
Identification of viral genes essential for replication of murine gamma-herpesvirus 68 using signature-tagged mutagenesis. Proc Natl Acad Sci U S A (2005) 1.98
Dissecting the host response to a gamma-herpesvirus. Philos Trans R Soc Lond B Biol Sci (2001) 1.89
Identification of the in vivo role of a viral bcl-2. J Exp Med (2002) 1.88
Characterization of gammaherpesvirus 68 gene 50 transcription. J Virol (2000) 1.84
Kinetic analysis of the specific host response to a murine gammaherpesvirus. J Virol (1998) 1.82
A gamma-herpesvirus sneaks through a CD8(+) T cell response primed to a lytic-phase epitope. Proc Natl Acad Sci U S A (1999) 1.78
Disruption of the M2 gene of murine gammaherpesvirus 68 alters splenic latency following intranasal, but not intraperitoneal, inoculation. J Virol (2002) 1.78
Immune control of the number and reactivation phenotype of cells latently infected with a gammaherpesvirus. J Virol (2002) 1.74
Virus-specific CD8(+) T cell numbers are maintained during gamma-herpesvirus reactivation in CD4-deficient mice. Proc Natl Acad Sci U S A (1998) 1.73
Gamma-herpesvirus kinase actively initiates a DNA damage response by inducing phosphorylation of H2AX to foster viral replication. Cell Host Microbe (2007) 1.71
The gammaherpesvirus 68 latency-associated nuclear antigen homolog is critical for the establishment of splenic latency. J Virol (2003) 1.70
Viral latency and its regulation: lessons from the gamma-herpesviruses. Cell Host Microbe (2010) 1.70
Establishment and maintenance of gammaherpesvirus latency are independent of infective dose and route of infection. J Virol (2003) 1.67
Selective gene expression of latent murine gammaherpesvirus 68 in B lymphocytes. J Virol (2003) 1.64
Control of gammaherpesvirus latency by latent antigen-specific CD8(+) T cells. J Exp Med (2000) 1.61
Murine gammaherpesvirus 68 encodes a functional regulator of complement activation. J Virol (1999) 1.51
Antibody to a lytic cycle viral protein decreases gammaherpesvirus latency in B-cell-deficient mice. J Virol (2002) 1.48
Murine gammaherpesvirus 68 infection is associated with lymphoproliferative disease and lymphoma in BALB beta2 microglobulin-deficient mice. J Virol (2005) 1.46
Latent antigen vaccination in a model gammaherpesvirus infection. J Virol (2001) 1.45
The murine gammaherpesvirus 68 v-cyclin gene is an oncogene that promotes cell cycle progression in primary lymphocytes. J Virol (1999) 1.42
Requirement for CD40 ligand, CD4(+) T cells, and B cells in an infectious mononucleosis-like syndrome. J Virol (1999) 1.41
Inhibition of NF-kappaB activation in vivo impairs establishment of gammaherpesvirus latency. PLoS Pathog (2007) 1.39
Viral infection of the placenta leads to fetal inflammation and sensitization to bacterial products predisposing to preterm labor. J Immunol (2010) 1.39
Interleukin 21 signaling in B cells is required for efficient establishment of murine gammaherpesvirus latency. PLoS Pathog (2015) 1.38
Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells. J Virol (2004) 1.36
Alpha/beta interferons regulate murine gammaherpesvirus latent gene expression and reactivation from latency. J Virol (2005) 1.35
The CD8 T-cell response against murine gammaherpesvirus 68 is directed toward a broad repertoire of epitopes from both early and late antigens. J Virol (2008) 1.35
Postexposure vaccination massively increases the prevalence of gamma-herpesvirus-specific CD8+ T cells but confers minimal survival advantage on CD4-deficient mice. Proc Natl Acad Sci U S A (2000) 1.34
Critical role for a high-affinity chemokine-binding protein in gamma-herpesvirus-induced lethal meningitis. J Clin Invest (2002) 1.34
Identification of infected B-cell populations by using a recombinant murine gammaherpesvirus 68 expressing a fluorescent protein. J Virol (2009) 1.31
A gammaherpesvirus-secreted activator of Vbeta4+ CD8+ T cells regulates chronic infection and immunopathology. J Exp Med (2008) 1.31
A surface groove essential for viral Bcl-2 function during chronic infection in vivo. PLoS Pathog (2005) 1.30
An optimized CD4 T-cell response can control productive and latent gammaherpesvirus infection. J Virol (2004) 1.28
Ongoing viral replication is required for gammaherpesvirus 68-induced vascular damage. J Virol (2000) 1.26
Characterization of a spontaneous 9.5-kilobase-deletion mutant of murine gammaherpesvirus 68 reveals tissue-specific genetic requirements for latency. J Virol (2002) 1.25
Gamma interferon blocks gammaherpesvirus reactivation from latency. J Virol (2006) 1.25
Murine gammaherpesvirus 68 cyclin D homologue is required for efficient reactivation from latency. J Virol (2000) 1.24
The murine gammaherpesvirus 68 M2 gene is required for efficient reactivation from latently infected B cells. J Virol (2005) 1.22
In vivo imaging of murid herpesvirus-4 infection. J Gen Virol (2009) 1.21
Effective vaccination against long-term gammaherpesvirus latency. J Virol (2003) 1.19
Autophagy Genes Enhance Murine Gammaherpesvirus 68 Reactivation from Latency by Preventing Virus-Induced Systemic Inflammation. Cell Host Microbe (2016) 1.19
Gamma interferon blocks gammaherpesvirus reactivation from latency in a cell type-specific manner. J Virol (2007) 1.18
Role of B-cell proliferation in the establishment of gammaherpesvirus latency. J Virol (2005) 1.15
Quantitative analysis of the acute and long-term CD4(+) T-cell response to a persistent gammaherpesvirus. J Virol (1999) 1.15
Ataxia telangiectasia mutated kinase controls chronic gammaherpesvirus infection. J Virol (2012) 1.14
Murid herpesvirus 4 strain 68 M2 protein is a B-cell-associated antigen important for latency but not lymphocytosis. J Virol (2003) 1.14
Signaling through Toll-like receptors induces murine gammaherpesvirus 68 reactivation in vivo. J Virol (2008) 1.14
Phenotypic complementation of genetic immunodeficiency by chronic herpesvirus infection. Elife (2015) 1.13
A gammaherpesvirus 68 gene 50 null mutant establishes long-term latency in the lung but fails to vaccinate against a wild-type virus challenge. J Virol (2006) 1.11
Analysis of a novel strain of murine gammaherpesvirus reveals a genomic locus important for acute pathogenesis. J Virol (2001) 1.11
Maintenance of gammaherpesvirus latency requires viral cyclin in the absence of B lymphocytes. J Virol (2003) 1.08
Antibody-independent control of gamma-herpesvirus latency via B cell induction of anti-viral T cell responses. PLoS Pathog (2006) 1.08
Tracking murine gammaherpesvirus 68 infection of germinal center B cells in vivo. PLoS One (2012) 1.05
Role for MyD88 signaling in murine gammaherpesvirus 68 latency. J Virol (2008) 1.05
Murine gammaherpesvirus 68 has evolved gamma interferon and stat1-repressible promoters for the lytic switch gene 50. J Virol (2010) 1.01
Murid herpesvirus-4 exploits dendritic cells to infect B cells. PLoS Pathog (2011) 1.00
Ex vivo stimulation of B cells latently infected with gammaherpesvirus 68 triggers reactivation from latency. J Virol (2005) 1.00
ORF73-null murine gammaherpesvirus 68 reveals roles for mLANA and p53 in virus replication. J Virol (2007) 0.99
Redefining the genetics of murine gammaherpesvirus 68 via transcriptome-based annotation. Cell Host Microbe (2010) 0.98
Endothelial cells support persistent gammaherpesvirus 68 infection. PLoS Pathog (2008) 0.98
Critical role of CD4 T cells in an antibody-independent mechanism of vaccination against gammaherpesvirus latency. J Virol (2004) 0.98
Murine gammaherpesvirus 68 infection of IFNgamma unresponsive mice: a small animal model for gammaherpesvirus-associated B-cell lymphoproliferative disease. Cancer Res (2009) 0.98
A gammaherpesvirus ubiquitin-specific protease is involved in the establishment of murine gammaherpesvirus 68 infection. J Virol (2009) 0.97
NF-kappaB p50 plays distinct roles in the establishment and control of murine gammaherpesvirus 68 latency. J Virol (2009) 0.97
Gammaherpesvirus latency accentuates EAE pathogenesis: relevance to Epstein-Barr virus and multiple sclerosis. PLoS Pathog (2012) 0.96
Establishment and maintenance of long-term murine gammaherpesvirus 68 latency in B cells in the absence of CD40. J Virol (2005) 0.96
Evidence for CDK-dependent and CDK-independent functions of the murine gammaherpesvirus 68 v-cyclin. J Virol (2006) 0.96
An optimized CD8+ T-cell response controls productive and latent gammaherpesvirus infection. J Virol (2005) 0.96
Identification and sequencing of a novel rodent gammaherpesvirus that establishes acute and latent infection in laboratory mice. J Virol (2011) 0.95
Histone deacetylases and the nuclear receptor corepressor regulate lytic-latent switch gene 50 in murine gammaherpesvirus 68-infected macrophages. J Virol (2010) 0.95
Tiled microarray identification of novel viral transcript structures and distinct transcriptional profiles during two modes of productive murine gammaherpesvirus 68 infection. J Virol (2012) 0.95
Immature and transitional B cells are latency reservoirs for a gammaherpesvirus. J Virol (2010) 0.95
A gammaherpesvirus cooperates with interferon-alpha/beta-induced IRF2 to halt viral replication, control reactivation, and minimize host lethality. PLoS Pathog (2011) 0.93
In vivo function of a gammaherpesvirus virion glycoprotein: influence on B-cell infection and mononucleosis. J Virol (2004) 0.93
Expansion of murine gammaherpesvirus latently infected B cells requires T follicular help. PLoS Pathog (2014) 0.93
Turnover of T cells in murine gammaherpesvirus 68-infected mice. J Virol (1999) 0.93
Use of a virus-encoded enzymatic marker reveals that a stable fraction of memory B cells expresses latency-associated nuclear antigen throughout chronic gammaherpesvirus infection. J Virol (2010) 0.92
Effective control of chronic gamma-herpesvirus infection by unconventional MHC Class Ia-independent CD8 T cells. PLoS Pathog (2006) 0.91
Murine gammaherpesvirus M2 protein induction of IRF4 via the NFAT pathway leads to IL-10 expression in B cells. PLoS Pathog (2014) 0.91
Identification of closely spaced but distinct transcription initiation sites for the murine gammaherpesvirus 68 latency-associated M2 gene. J Virol (2008) 0.90
Murine gammaherpesvirus 68 LANA is essential for virus reactivation from splenocytes but not long-term carriage of viral genome. J Virol (2010) 0.89
Unbiased mutagenesis of MHV68 LANA reveals a DNA-binding domain required for LANA function in vitro and in vivo. PLoS Pathog (2012) 0.89
Induction of protective immunity against murine gammaherpesvirus 68 infection in the absence of viral latency. J Virol (2009) 0.89
Systematic mutagenesis of the murine gammaherpesvirus 68 M2 protein identifies domains important for chronic infection. J Virol (2008) 0.89
Dynamic association of gammaherpesvirus DNA with core histone during de novo lytic infection of primary cells. Virology (2011) 0.88
Granzymes and caspase 3 play important roles in control of gammaherpesvirus latency. J Virol (2004) 0.88
A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature (1991) 13.19
CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J Virol (1994) 10.03
Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells. Science (1990) 8.17
Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo. J Gen Virol (1992) 5.42
Virological and pathological features of mice infected with murine gamma-herpesvirus 68. J Gen Virol (1992) 5.02
Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature (1995) 4.53
Murine herpesvirus 68 is genetically related to the gammaherpesviruses Epstein-Barr virus and herpesvirus saimiri. J Gen Virol (1990) 3.41
Cloning and molecular characterization of the murine herpesvirus 68 genome. J Gen Virol (1990) 3.33
Delayed clearance of Sendai virus in mice lacking class I MHC-restricted CD8+ T cells. J Immunol (1992) 3.31
Isolation of five strains of herpesviruses from two species of free living small rodents. Acta Virol (1980) 3.09
LCMV-specific, class II-restricted cytotoxic T cells in beta 2-microglobulin-deficient mice. Science (1992) 2.98
Pathogenesis of murine gammaherpesvirus infection in mice deficient in CD4 and CD8 T cells. J Virol (1993) 2.93
Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency. Proc Natl Acad Sci U S A (1988) 2.12
Impairment and delay of neutralizing antiviral antibody responses by virus-specific cytotoxic T cells. J Immunol (1993) 2.10
Theiler's virus infection of beta 2-microglobulin-deficient mice. J Virol (1993) 2.04
Latency, without persistence, of murine cytomegalovirus in the spleen and kidney. J Virol (1995) 1.91
Abrogation of resistance to Theiler's virus-induced demyelination in H-2b mice deficient in beta 2-microglobulin. J Immunol (1993) 1.85
Pathogenesis of acute and persistent murine herpesvirus infection in mice. Acta Virol (1985) 1.78
Antiviral immune responses of lymphocytic choriomeningitis virus-infected mice lacking CD8+ T lymphocytes because of disruption of the beta 2-microglobulin gene. J Virol (1993) 1.76
Expression of Epstein-Barr virus-encoded growth-transformation-associated proteins in lymphoproliferations of bone-marrow transplant recipients. Int J Cancer (1991) 1.36
Characterization of murine gammaherpesvirus 68 glycoprotein B (gB) homolog: similarity to Epstein-Barr virus gB (gp110). J Virol (1994) 1.35
Ecology of the murine alphaherpesvirus and its isolation from lungs of rodents in cell culture. Acta Virol (1985) 1.29
Lymphocytic choriomeningitis virus induces a chronic wasting disease in mice lacking class I major histocompatibility complex glycoproteins. J Neuroimmunol (1993) 1.21
Experimental pathogenesis of murine herpesvirus in newborn mice. Acta Virol (1984) 1.21
Mice lacking CD8+ T cells develop greater numbers of IgA-producing cells in response to a respiratory virus infection. Virology (1994) 1.17
Divergence between cytotoxic effector function and tumor necrosis factor alpha production for inflammatory CD4+ T cells from mice with Sendai virus pneumonia. J Virol (1993) 1.13
MHC class I molecule-restricted presentation of viral antigen in beta 2-microglobulin-deficient mice. J Immunol (1994) 1.11
Serological and molecular studies of Epstein-Barr virus infection in allogeneic marrow graft recipients. Transplantation (1990) 1.09
Detection of multiple Epstein-Barr viral strains in allogeneic bone marrow transplant recipients. J Med Virol (1992) 1.01
Induction of peptide-specific CD8+ CTL clones in beta 2-microglobulin-deficient mice. J Immunol (1995) 1.00
Persistence and transfer of Epstein-Barr virus after allogeneic bone marrow transplantation. Transplant Proc (1989) 0.86
Complete sequence and genomic analysis of murine gammaherpesvirus 68. J Virol (1997) 7.71
Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells. J Virol (1999) 4.12
Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1. J Virol (1990) 4.09
Murine gamma-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-gamma responsiveness: a new model for virus-induced vascular disease. Nat Med (1997) 3.40
Analysis of the transcript encoding the latent Epstein-Barr virus nuclear antigen I: a potentially polycistronic message generated by long-range splicing of several exons. Proc Natl Acad Sci U S A (1985) 3.35
Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes. Proc Natl Acad Sci U S A (1990) 3.29
Identification of phorbol ester response elements in the promoter of Epstein-Barr virus putative lytic switch gene BZLF1. J Virol (1990) 3.09
Mutually exclusive use of viral promoters in Epstein-Barr virus latently infected lymphocytes. Proc Natl Acad Sci U S A (1989) 2.88
Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus. J Virol (1989) 2.86
B cells regulate murine gammaherpesvirus 68 latency. J Virol (1999) 2.79
An Epstein-Barr virus transcript from a latently infected, growth-transformed B-cell line encodes a highly repetitive polypeptide. Proc Natl Acad Sci U S A (1986) 2.66
E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc Natl Acad Sci U S A (1993) 2.61
Three distinct regions of the murine gammaherpesvirus 68 genome are transcriptionally active in latently infected mice. J Virol (1999) 2.56
Role for the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection. Proc Natl Acad Sci U S A (1991) 2.54
Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes. Proc Natl Acad Sci U S A (1991) 2.40
Disruption of the murine gammaherpesvirus 68 M1 open reading frame leads to enhanced reactivation from latency. J Virol (2000) 2.33
Unraveling immunity to gamma-herpesviruses: a new model for understanding the role of immunity in chronic virus infection. Curr Opin Immunol (1999) 2.19
Identification of critical cis elements involved in mediating Epstein-Barr virus nuclear antigen 2-dependent activity of an enhancer located upstream of the viral BamHI C promoter. J Virol (1992) 2.09
The murine gammaherpesvirus 68 v-cyclin is a critical regulator of reactivation from latency. J Virol (2000) 2.01
Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines. Proc Natl Acad Sci U S A (1995) 1.89
Identification of a gammaherpesvirus selective chemokine binding protein that inhibits chemokine action. J Virol (2000) 1.86
Characterization of gammaherpesvirus 68 gene 50 transcription. J Virol (2000) 1.84
Cyclosporin A-sensitive induction of the Epstein-Barr virus lytic switch is mediated via a novel pathway involving a MEF2 family member. EMBO J (1997) 1.82
Evidence for coiled-coil dimer formation by an Epstein-Barr virus transactivator that lacks a heptad repeat of leucine residues. Proc Natl Acad Sci U S A (1990) 1.79
Efficient transcription of the Epstein-Barr virus immediate-early BZLF1 and BRLF1 genes requires protein synthesis. J Virol (1991) 1.79
Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease. Nat Med (2000) 1.76
oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines. J Virol (1996) 1.67
ZEBRA and a Fos-GCN4 chimeric protein differ in their DNA-binding specificities for sites in the Epstein-Barr virus BZLF1 promoter. J Virol (1991) 1.56
Characterization of the Epstein-Barr virus BZLF1 protein transactivation domain. J Virol (1992) 1.54
Identification and initial characterization of the murine gammaherpesvirus 68 gene M3, encoding an abundantly secreted protein. J Virol (1999) 1.52
Murine gammaherpesvirus 68 encodes a functional regulator of complement activation. J Virol (1999) 1.51
Complex transcription of the Epstein-Barr virus BamHI fragment H rightward open reading frame 1 (BHRF1) in latently and lytically infected B lymphocytes. Proc Natl Acad Sci U S A (1988) 1.47
Definition of cytochrome c binding domains by chemical modification: kinetics of reaction with beef mitochondrial reductase and functional organization of the respiratory chain. Proc Natl Acad Sci U S A (1979) 1.44
The murine gammaherpesvirus 68 v-cyclin gene is an oncogene that promotes cell cycle progression in primary lymphocytes. J Virol (1999) 1.42
Epstein-Barr virus BZLF1 trans activator induces the promoter of a cellular cognate gene, c-fos. J Virol (1990) 1.41
IFN-gamma action in the media of the great elastic arteries, a novel immunoprivileged site. J Clin Invest (2001) 1.39
Alternative splicing dictates translational start in Epstein-Barr virus transcripts. EMBO J (1990) 1.38
Isolation and characterization of cDNA clones corresponding to transcripts from the BamHI H and F regions of the Epstein-Barr virus genome. J Virol (1987) 1.34
Identification and mapping of polypeptides encoded by the P3HR-1 strain of Epstein-Barr virus. Proc Natl Acad Sci U S A (1984) 1.31
Spliced mRNA encoding the murine cytomegalovirus chemokine homolog predicts a beta chemokine of novel structure. J Virol (1999) 1.29
Host-cell-determined methylation of specific Epstein-Barr virus promoters regulates the choice between distinct viral latency programs. Mol Cell Biol (1997) 1.28
Differential methylation of Epstein-Barr virus latency promoters facilitates viral persistence in healthy seropositive individuals. J Virol (1999) 1.28
Identification of a negative cis element within the ZII domain of the Epstein-Barr virus lytic switch BZLF1 gene promoter. J Virol (1998) 1.28
Ongoing viral replication is required for gammaherpesvirus 68-induced vascular damage. J Virol (2000) 1.26
DNA-binding-defective mutants of the Epstein-Barr virus lytic switch activator Zta transactivate with altered specificities. Mol Cell Biol (1994) 1.25
The Epstein-Barr virus BamHI F promoter is an early lytic promoter: lack of correlation with EBNA 1 gene transcription in group 1 Burkitt's lymphoma cell lines. J Virol (1995) 1.24
Regulation of the BZLF1 promoter of Epstein-Barr virus by second messengers in anti-immunoglobulin-treated B cells. Virology (1994) 1.24
Characterization of the ZI domains in the Epstein-Barr virus BZLF1 gene promoter: role in phorbol ester induction. J Virol (1996) 1.22
Characterization of a cDNA clone corresponding to a transcript from the Epstein-Barr virus BamHI M fragment: evidence for overlapping mRNAs. J Virol (1987) 1.18
The reaction of primate cytochromes c with cytochrome c oxidase. Analysis of the polarographic assay. J Biol Chem (1983) 1.18
Binding of the ubiquitous cellular transcription factors Sp1 and Sp3 to the ZI domains in the Epstein-Barr virus lytic switch BZLF1 gene promoter. Virology (1997) 1.18
Murine cytomegalovirus infection inhibits IFN gamma-induced MHC class II expression on macrophages: the role of type I interferon. Virology (1998) 1.18
Constitutive activation of Epstein-Barr virus (EBV) nuclear antigen 1 gene transcription by IRF1 and IRF2 during restricted EBV latency. Mol Cell Biol (1997) 1.16
Regulation of EBNA gene transcription in lymphoblastoid cell lines: characterization of sequences downstream of BCR2 (Cp). J Virol (1997) 1.16
Genetic mapping of reovirus virulence and organ tropism in severe combined immunodeficient mice: organ-specific virulence genes. J Virol (1995) 1.13
B-cell lines immortalized with an Epstein-Barr virus mutant lacking the Cp EBNA2 enhancer are biased toward utilization of the oriP-proximal EBNA gene promoter Wp1. J Virol (1997) 1.12
Cyclosporin A and FK506 block induction of the Epstein-Barr virus lytic cycle by anti-immunoglobulin. Virology (1995) 1.04
A simple reverse transcriptase PCR assay to distinguish EBNA1 gene transcripts associated with type I and II latency from those arising during induction of the viral lytic cycle. J Virol (1996) 1.03
Transcription of the tumor necrosis factor alpha gene is rapidly induced by anti-immunoglobulin and blocked by cyclosporin A and FK506 in human B cells. Proc Natl Acad Sci U S A (1992) 1.03
The Epstein-Barr virus-induced Ca2+/calmodulin-dependent kinase type IV/Gr promotes a Ca(2+)-dependent switch from latency to viral replication. J Virol (1997) 1.01
Epstein-Barr virus transformation. Prog Nucleic Acid Res Mol Biol (1987) 0.98
Single catalytic site model for the oxidation of ferrocytochrome c by mitochondrial cytochrome c oxidase. Proc Natl Acad Sci U S A (1984) 0.94
Characterization of the interaction of cytochrome c and mitochondrial ubiquinol-cytochrome c reductase. J Biol Chem (1984) 0.92
Epstein-Barr virus in B lymphocytes: viral gene expression and function in latency. Adv Cancer Res (1992) 0.89
Copper electron-nuclear double resonance of cytochrome c oxidase. Proc Natl Acad Sci U S A (1980) 0.88
Bidirectional transcription of the Epstein-Barr virus major internal repeat. J Virol (1990) 0.85
Interaction of cytochrome c with the blue copper proteins, plastocyanin and azurin. J Biol Chem (1983) 0.84
Role of phospholipid in the low affinity reactions between cytochrome c and cytochrome oxidase. FEBS Lett (1983) 0.83
The presteady state reaction of chemically modified cytochromes c with cytochrome oxidase. J Biol Chem (1983) 0.82
Preferred sites for electron transfer between cytochrome c and iron and cobalt complexes. J Biol Chem (1983) 0.80
Definition of cytochrome c binding domains by chemical modification. Interaction of horse cytochrome c with beef sulfite oxidase and analysis of steady state kinetics. J Biol Chem (1981) 0.77
Brain- and intestine-specific variants of reovirus serotype 3 strain dearing are selected during chronic infection of severe combined immunodeficient mice. J Virol (1995) 0.76
Site-specific anti-cytochrome c antibodies. Inhibition of the reactions between cytochrome c and its respiratory chain electron exchange partners. J Biol Chem (1979) 0.75